Cartesian Therapeutics ratios data for the quarter ended Jun 2026. These financial ratios cover 45 quarters of results from Jun 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||||||||||
| EBT Margin | -8.46% | 41.34% | 29.65% | 34.00% | -39.66% | 33.37% | -322.97% | -342.85% | -137.41% | -2,379.12% | -208.63% | 44.71% | -3,876.49% | 3,198.55% | -1,806.73% | -6,732.55% | -4,318.14% | -8,170.12% | -32,657.69% | ||||||||||||||||||||||||||
| EBIT Margin | -8.06% | 13.62% | 31.69% | 35.29% | -7.72% | -50.59% | -309.55% | -355.08% | -199.44% | -439.54% | -228.56% | 41.13% | -4,541.34% | 3,521.87% | -1,989.91% | -7,319.13% | -4,660.62% | -8,304.01% | -33,973.08% | ||||||||||||||||||||||||||
| EBITDA Margin | -8.06% | 13.62% | 31.69% | 35.29% | -7.72% | -50.59% | -309.55% | -355.08% | -199.44% | -439.54% | -228.56% | 41.13% | -4,541.34% | 3,521.87% | -1,989.91% | -7,319.13% | -4,660.62% | -8,304.01% | -33,973.08% | ||||||||||||||||||||||||||
| Operating Margin | -8.06% | 13.62% | 31.69% | 35.29% | -7.72% | -50.59% | -309.55% | -355.08% | -199.44% | -439.54% | -228.56% | 41.13% | -4,541.34% | 3,521.87% | -1,989.91% | -7,319.13% | -4,660.62% | -8,304.01% | -33,973.08% | ||||||||||||||||||||||||||
| Net Margin | -73.26% | 40.88% | 29.65% | 34.00% | -38.11% | 35.09% | -322.97% | -216.94% | -137.41% | -2,379.12% | -208.63% | 28.79% | -3,876.49% | 3,198.55% | -1,806.73% | 4,448.99% | -4,318.14% | -8,170.12% | -32,657.69% | ||||||||||||||||||||||||||
| FCF Margin | -44.66% | -106.02% | -36.23% | -31.50% | 18.91% | -71.81% | -149.80% | -188.74% | -140.67% | -282.48% | -282.86% | -50.00% | 2,114.21% | 1,015.42% | -2,198.45% | -6,750.34% | -3,737.17% | -1,922.28% | -28,453.85% | ||||||||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 0.17B | 0.16B | 0.15B | 0.17B | 0.18B | 0.17B | 0.16B | 0.15B | 0.12B | 0.21B | 0.32B | 0.34B | 0.40B | 0.45B | 0.42B | 0.40B | 0.38B | 0.33B | 0.29B | 0.30B | |||||||||||||||||||||||||
| Invested CapitalInvested Cap. | 0.01B | 0.05B | 0.08B | 0.12B | 0.11B | 0.12B | 0.10B | 0.09B | 0.06B | -0.41B | -0.12B | -0.10B | 0.00B | -0.01B | -0.13B | -0.07B | |||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.39 | 0.52 | 0.71 | 0.76 | 0.68 | 0.64 | 0.51 | 0.33 | 0.28 | 0.13 | 0.08 | 0.16 | 0.12 | 0.09 | 0.08 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | |||||||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -2.77 | 5.74 | 15.24 | 19.38 | -1.99 | -10.53 | -22.75 | -24.78 | -10.26 | -34.22 | |||||||||||||||||||||||||||||||||||
| Debt Ratio | 0.15 | 0.16 | 0.18 | 0.14 | 0.15 | 0.16 | 0.17 | 0.17 | 0.09 | 0.17 | |||||||||||||||||||||||||||||||||||
| Times Interest Earned | -2.77 | 5.74 | 15.24 | 19.38 | -1.99 | -10.53 | -22.75 | -24.78 | -10.26 | -34.22 | |||||||||||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -805.15 | 987.85 | 455.28 | 449.49 | -953.89 | 880.39 | -333.61 | -452.72 | -547.03 | -17.02 | -8.83 | 49.98 | -25.68 | -12.75 | -17.20 | 20.38 | -13.62 | -2.42 | -6.89 | 22.81 | |||||||||||||||||||||||||
| Price to SalesP/S | 589.81 | 403.86 | 134.99 | 152.82 | 363.55 | 308.91 | 0.00B | 982.12 | 751.70 | 404.92 | 18.42 | 14.39 | 995.38 | -407.68 | 310.76 | 906.51 | 587.96 | 198.04 | 0.00B | ||||||||||||||||||||||||||
| Price to BookP/B | -769.17 | 536.85 | 82.30 | 66.98 | 88.67 | 55.29 | 85.79 | 78.77 | 81.63 | -7.60 | -0.92 | -4.74 | 512.25 | -45.49 | -15.69 | -106.90 | -7.41 | -1.49 | -1.19 | -2.50 | |||||||||||||||||||||||||
| Enterprise Value | 14.27B | 11.96B | 4.47B | 5.86B | 7.38B | 5.05B | 6.27B | 5.04B | 4.84B | 3.27B | 0.00B | 0.39B | 0.17B | 0.10B | 0.16B | 0.11B | 0.12B | 0.06B | 0.06B | 0.17B | |||||||||||||||||||||||||
| EV to EBIT | -0.00B | 0.00B | 415.13 | 422.77 | -0.00B | -594.81 | -341.22 | -270.58 | -370.82 | -90.01 | -0.31 | 28.64 | -9.45 | -3.62 | -7.37 | -5.03 | -5.81 | -0.79 | -2.15 | -5.67 | |||||||||||||||||||||||||
| EV to EBITDA | -0.00B | 0.00B | 415.13 | 422.77 | -0.00B | -594.81 | -341.22 | -270.58 | -370.82 | -90.01 | -0.31 | 28.64 | -9.45 | -3.62 | -7.37 | -5.03 | -5.81 | -0.79 | -2.15 | -5.67 | |||||||||||||||||||||||||
| Market Capitalization | 14.41B | 12.09B | 4.59B | 6.00B | 7.53B | 5.19B | 6.40B | 5.16B | 4.92B | 3.35B | 0.11B | 0.48B | 0.39B | 0.31B | 0.34B | 0.27B | 0.27B | 0.19B | 0.18B | 0.31B | |||||||||||||||||||||||||
| Price to FCFP/FCF | -0.00B | -380.94 | -372.57 | -485.18 | 0.00B | -430.19 | -719.27 | -520.36 | -534.39 | -143.34 | -6.51 | -28.78 | 47.08 | -40.15 | -14.14 | -13.43 | -15.73 | -10.30 | -7.91 | -14.68 | |||||||||||||||||||||||||
| EV to FCF | -0.00B | -376.91 | -363.03 | -473.69 | 0.00B | -419.03 | -705.11 | -509.05 | -525.75 | -140.05 | -0.25 | -23.56 | 20.29 | -12.56 | -6.67 | -5.46 | -7.24 | -3.43 | -2.56 | -7.76 | |||||||||||||||||||||||||
| EV to CFO | -0.00B | -380.24 | -376.96 | -477.51 | 0.00B | -426.49 | -715.57 | -509.67 | -525.75 | -140.43 | -0.26 | -27.27 | 12.13 | -13.83 | -6.98 | -6.27 | -7.84 | -3.52 | -2.57 | -7.85 | |||||||||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -8.06% | 13.62% | 31.69% | 35.29% | -7.72% | -50.59% | -309.55% | -355.08% | -199.44% | -439.54% | -228.56% | 41.13% | -4,541.34% | 3,521.87% | -1,989.91% | -7,319.13% | -4,660.62% | -8,304.01% | -33,973.08% | -10,518.55% | |||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -21.19% | -5.04% | 11.74% | 20.09% | 17.00% | 9.89% | -10.89% | -39.85% | -56.97% | -62.92% | -29.22% | -15.78% | -14.07% | -10.40% | -12.88% | -22.75% | -24.93% | -44.87% | -53.54% | -54.91% | |||||||||||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | 105.83% | 10.37% | 3.30% | ||||||||||||||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -23.85% | -8.43% | 2.73% | 10.65% | 15.17% | 12.46% | -4.87% | -26.54% | -32.81% | -118.14% | -74.84% | -60.30% | -52.02% | -8.20% | -10.47% | -19.85% | -21.99% | -40.90% | -48.71% | -49.84% |